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Pathovars of Pseudomonas syringae interact with their plant
hosts via the action of Hrp outer protein (Hop) effector
proteins, injected into plant cells by the type III secretion
system (TTSS). Recent availability of complete genome sequences for a number of P. syringae pathovars has led to a
significant increase in the rate of effector discovery. However, lack of a systematic nomenclature has resulted in
multiple names being assigned to the same Hop, unrelated
Hops designated by the same alphabetic character, and
failure of name choices to reflect consistent standards of
experimental confirmation or phylogenetic relatedness.
Therefore, specific experimental and bioinformatic criteria
are proposed for proteins to be designated as Hops. A generic Hop name structure, HopXY#pv strain, also is proposed,
wherein family membership is indicated by the alphabetic
characters, subgroup membership numerically, and source
pathovar and strain in subscript. Guidelines are provided
for phylogenetic characterization and name selection for
Hops that are novel, related to previously characterized
Hops, chimeras, pseudogenes, truncations, or nonexpressed
alleles. Phylogenetic analyses of previously characterized
Hops are described, the results of which have been used to
guide their integration into the proposed nomenclature.
The bacterial plant pathogen Pseudomonas syringae comprises a large collection of pathovars and strains noted for their
diverse and highly specific interactions with plant hosts. The
bacterium–host interaction is governed in large part by effector
proteins, which are injected into plant cells by the type III secretion system (TTSS) and are discussed in detail in recent
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reviews (Alfano and Collmer 2004; Chang et al. 2004;
Collmer et al. 2002; Greenberg and Vinatzer 2003; Jin et al.
2003). TTSS substrates have been identified by various phenotypic characteristics over the last 20 years, but the recent availability of partial and completed genome sequences for a number of P. syringae pathovars has greatly increased the rate of
effector discovery and the number of published, named effectors (Buell et al. 2003; Fouts et al. 1997; Greenberg and Vinatzer
2003; Guttman et al. 2002; Petnicki-Ocwieja et al. 2002;
Zwiesler-Vollick et al. 2002).
The history of effector nomenclature generally reflects developments in our understanding of host–pathogen interactions in
P. syringae. The first generation of effectors, identified by their
ability to induce an avirulence reaction in plants carrying the
corresponding resistance gene, was given the Avr designation.
Many of these were named according to guidelines proposed by
Vivian and Mansfield (1993). Following the identification of a
TTSS in P. syringae and demonstration that virulence factors,
including most of the Avr proteins, were substrates for this pathway, proteins targeted to the TTSS were given the Hrp outer
protein (Hop) designation (Alfano and Collmer 1997), reflecting
the Yersinia outer protein (Yop) precedence for the prototypical
TTSS effectors (Cornelis and Van Gijsegem 2000).
However, the naming of individual Hop genes and proteins
has not been coordinated among different research groups,
leading to a situation where i) multiple names have been assigned to the same Hop, ii) unrelated Hops are designated by
the same alphabetic character, iii) name choices do not reflect
consistent standards of experimental determination or phylogenetic relatedness, and iv) named Hop “candidates” have proliferated, identified on the basis of conserved regulatory or targeting patterns, but lacking experimental evidence for expression or passage through the TTSS. With genome sequences
already generated for three P. syringae pathovars and various
strategies expected to generate more Hops and Hop candidates, the need for clear and consistent guidelines for Hop nomenclature has become apparent.
To address these problems, a set of standards for Hop nomenclature and name assignment are suggested. These guidelines
i) specify criteria for a protein to become a named Hop, ii)
codify a nomenclature system for Hops, Hop homologs, and
Vol. 18, No. 4, 2005 / 275

their chaperones, and iii) outline recommended procedures for
assignment of new names. Phylogenetic analyses of previously
published Hops were conducted as a first step in the implementation of the new nomenclature guidelines and are discussed
here in detail. Evolutionary analyses of some of these sequences
also have been recently published (Rohmer et al. 2004). The
results have been used to assign Hops to homology families
and subgroups, and to guide the assignment of new names.
Criteria for Hop name assignment.
The term “Hop” applies generically to expressed proteins that
are secreted or translocated by the TTSS of P. syringae and related plant pathogens. A typical hop gene is preceded by an Hrp
box promoter, is activated by the HrpL alternative sigma factor,
and encodes a protein with N-terminal sequences that target it to
the TTSS pathway for secretion in culture or translocation in
planta, hereafter referred to as a TTSS targeting pattern. Because
Hops are host range determinants whose presence can be specifically recognized by plants, it is likely that production of
some members of a given Hop family will be disrupted in some
P. syringae host-specific pathovars, races, or strains.
The majority of proteins that meet these criteria for expression and secretion or translocation are likely to be true effectors, with their primary function within the host cell (Cornelis
and Van Gijsegem 2000). However, a subset of TTSS substrates may have a role as translocators or helpers assisting the
delivery of true effectors across host cell barriers. The nomenclature system described here does not distinguish between
effectors and translocators, and all proteins traveling the TTSS
pathway will be considered Hops.
The best evidence for Hop name assignment is experimental
verification of both expression and TTSS-dependent secretion
or translocation; however, exclusive reliance on such stringent
requirements would significantly delay name assignment to
promising candidates. To ease the experimental burden required
for Hop naming while minimizing the generation of artifactual
Hops and Hop families, experimental evidence can be supplemented with computational or bioinformatic data, as described
in criteria B and C (below). Homology with previously characterized Hops (criterion A) and evidence of function in planta
(criterion D) also are accepted as evidence.
In order for newly identified proteins to receive a Hop designation, it is recommended that one or more of the following
criteria be met.
A. Phylogenetic membership in an established Hop family
and a consensus N-terminal targeting pattern. If >60% of a new
protein’s sequence can be significantly aligned (e < 10–5) with
one or more members of a Hop family previously characterized
using criteria B, C, or D, the new protein can be given a Hop
name reflecting this relationship. However, for a more accurate
assessment of family and subgroup membership, the phylogenetic analyses described under “Implementation of Nomenclature Guidelines” are strongly recommended. The additional requirement for a TTSS targeting pattern (characteristics specified
under criterion B) is included so that Hop names will be limited
to those homologs that are plausible TTSS substrates.
If subsequent testing reveals that a protein named by this
criterion is not expressed, its gene name should be modified by
addition of the Greek letter psi (ψ) to reflect its status as a
pseudogene. Likewise, if a protein is later found not to be secreted, an asterisk can be appended to the name, indicating
that it is a nonsecreted allele (discussed in more detail in the
section entitled “Name Structure and Selection”).
B. Confirmed HrpL-dependence and a consensus TTSS targeting pattern. Proteins are eligible for a Hop designation if
HrpL dependence or expression in bacteria during infection or
in minimal media accepted as mimicking the plant apoplast is
276 / Molecular Plant-Microbe Interactions

experimentally confirmed, and if an N-terminal TTSS targeting pattern is present. Although the consensus properties of
this amino acid domain may change as more effectors are identified, the best information currently available indicates that most
proteins targeted to the TTSS have N-terminal regions characterized by the following: i) ≥10% Ser in the first 50 amino
acids, ii) Ile, Leu, Val, Ala, or Pro in the third or fourth position, and iii) no Asp or Glu residues in the first 12 amino acids
(Greenberg and Vinatzer 2003; Guttman et al. 2002; PetnickiOcwieja et al. 2002). It is expected that effectors named using
criterion B eventually will be tested for TTSS-dependent secretion or translocation. If they do not meet these criteria, their
name should be changed accordingly.
C. Hrp-dependent (TTSS) secretion or translocation and evidence of expression. Proteins are eligible for a Hop designation
if TTSS-dependent secretion or translocation is experimentally
confirmed and there is bioinformatic or experimental evidence
supporting the expression of at least one member of the Hop
family. Although passage through the TTSS is the defining
characteristic of Hop proteins, evidence of expression also is
required to avoid the proliferation of Hop families that have
been computationally identified and translocated under artificial conditions, but for which there is no evidence of actual
expression. Evidence of expression should include assessment
of the presence of an upstream Hrp box (Fouts et al. 2002; Innes
et al. 1993; Shen and Keen 1993; Xiao and Hutcheson 1994).
Accepted methods for demonstrating translocation include
showing that a reporter such as ′AvrRpt2 or Cya can be translocated into the cell interior in an Hrp-dependent manner when
fused to the full-length coding sequence of the candidate being
tested (Casper-Lindley et al. 2002; Mudgett et al. 2000;
Schechter et al. 2004).
D. Avirulence phenotype or hypersensitive response. Proteins
that induce an avirulent or hypersensitive response when expressed in heterologous bacteria can be named as Hops. However, subsequent demonstration of secretion or translocation is
encouraged, given that proteins such as AvrD, which direct the
production of low molecular-weight elicitors (Yucel et al. 1994),
are active in bacterial cells but may not be TTSS substrates.
Name structure and selection.
Generic name structure. The suggested Hop name structure,
designed to reflect both phylogenetic membership in families
and subgroups as well as information about the source
pathovar and strain, is: HopXY#pv strain.
Family. Individual Hops are grouped in homology families
according to sequence relatedness. Family membership is indicated by the alphabetic character or character combination,
shown in the generic name structure above as “XY”.
Subgroup. Whereas orthology and paralogy relationships of
Hops within a family generally are ignored due to the confounding effects of horizontal gene transfer, homology families can be further divided when the level of amino acid similarity is sufficiently high and the phylogenetic structure for
these subgroups is strong. Although there is no way to determine from sequence if these subgroups are functionally distinct, they represent distinct and strongly supported evolutionary lineages, and researchers are encouraged to use phylogenetic means to assign new Hops to families and subgroups.
Subgroup membership is indicated by the numerical designation following the alphabetic characters and can be determined
using the guidelines listed. It is suggested that the subgroup
designation “1” be assigned even in cases where the homology
family is not subdivided, in order to facilitate possible future
expansion of the family when additional members are identified. If a given strain is found to encode more than one member of a given family and subgroup, addition of a hyphenated

number (HopXY#-#pv strain) will be used to distinguish between
the copies. Instructions for determining family and subgroup
membership are described in “Phylogenetic Characterization
of Hop Protein Sequences”.
Source. Pathovar and strain of the source bacterium are to be
indicated in subscript. This format is generally consistent with
American Society for Microbiology guidelines for gene naming,
wherein genotypic designations are indicated by three-letter locus symbols, functionally related loci distinguished by capital
letters, and subscripts used to distinguish genes from different
organisms and strains. Pathovar abbreviations such as Pma and
Pto follow the recommendations of Vivian and Mansfield (1993)
and the update by D. S. Guttman published on the Pseudomonas–Plant Interaction website. Although strain designations have
not been included routinely in past Avr and Hop name assignments, the anticipated sequencing of multiple strains from single
pathovars necessitates their inclusion in the new nomenclature.
Nonhomologous Hops. If a Hop is confirmed by criteria B,
C, or D but is not homologous to any previously identified
Hop family, it will be assigned the next available alphabetic
character and the subgroup designation “1”, followed by a subscript indicating the pathovar and strain from which it was
identified. Once an alphabetic character or character combination has been assigned, it cannot be applied to Hops outside
that family. Once alphabetic characters A to Z have been assigned, naming shall proceed with AA, AB, AC…, BA, BB,
BC…, and so on.
Homologs of previously named hops. If BLAST analyses
reveal similarity with previously characterized Hops extending
over 60% of the new protein’s sequence, the new Hop can be
assigned the alphabetic character of the family, followed by
the appropriate pathovar and strain designation. However, researchers are strongly urged to perform the more detailed analyses described in “Phylogenetic Categorization of New Hops”. In
contrast to BLAST, a local alignment tool that groups sequences
according to high levels of similarity in relatively small regions,
the suggested procedures generate a more accurate alignment
of prospective family members along their entire sequence. In
addition, they provide guidelines for quantifying the degree of
evolutionary similarity among family members for their assignment to subgroups. The subgroup model is especially useful
when distinguishing among multiple homologs in the same
strain.
Chimeras. As a general rule, Hops for which a contiguous
stretch ≥40% of the coding region is unique or derived from an
unrelated Hop should be considered chimeras. All chimeras
thus far identified are composed of a region similar to a previously named Hop and a novel coding sequence. These have
been assigned a unique alphabetic designation. If Hops are identified that appear to be chimeras composed of two previously
characterized Hops, it is recommended that they be named
using the alphabetic characters of both parents (e.g., a chimera
Hop composed of regions from HopABpv strain and HopXYpv
strain would be named HopAB-XYpv strain).
Pseudogenes. Nonexpressed homologs of characterized Hop
families can be named according to the convention for bacterial pseudogenes wherein the gene name is preceded by the
Greek letter ψ (e.g., ψhopXY1pv strain).
Nonsecreted or translocated alleles. Homologs that are expressed but neither secreted nor translocated can be named
after the Hop family and subgroup to which they are homologous followed by an asterisk (e.g., HopXY1 * pv strain). Experimental confirmation of this phenotype is strongly encouraged,
because not all Hops have an obvious N-terminal secretion or
translocation domain.
Gene disruptions. Homologs of previously characterized
hop genes that are truncated by a frame shift or premature stop

codon can be indicated by addition of a single quotation mark
to the hop gene name (i.e., hopXY’pv strain). If a disrupted gene
fails to be expressed, a ψ also can be added to reflect pseudogene status. Insertions by mobile genetic elements can be
indicated with a double colon followed by the name of the
inserted element (i.e., hopXY::IS10pv strain).
Hop candidates. Although the range of criteria described
above should eliminate the need to name Hop candidates, and
understanding that naming of candidates can lead to downstream confusion, researchers who choose to name candidates
are strongly urged to minimize name proliferation by depositing the sequences in GenBank under the provisional name
“candidate Hop protein” and referring to them in print by their
GenBank accession numbers rather than by provisional threeletter gene names. Interesting homologies or other properties
can be indicated in the “Note” field in the GenBank submission. GenBank records of candidates or Hops named according
to criterion C should be updated with secretion or translocation
data and any name changes should be made in a timely fashion.
Hop chaperones. Three Hop chaperones have been experimentally confirmed and named with the designation “specific
Hop chaperone” (Shc) followed by the letter of the first Hop
for which they were shown to be a chaperone (Badel et al.
2003; van Dijk et al. 2002; Wehling et al. 2004). This designation was chosen to parallel the Yersinia spp. term “specific
Yersinia chaperone” (Syc) (Wattiau and Cornelis 1993). Acceptable evidence for chaperone activity includes any method that
directly demonstrates association of the chaperone and its cognate Hop, such as affinity chromatography, immunoblotting,
yeast two-hybrid experiments, or crystal structure. In addition,
a decrease in Hrp-dependent secretion of the chaperoned protein
should be evident upon mutagenesis of the chaperone gene.
Phylogenetic analysis of previously characterized Hops.
Adoption of a new nomenclature system not only establishes
suggested guidelines for naming new Hops but also provides
an opportunity to rename previously identified Hops according
to consistent phylogenetic standards.
Methodology.
To initiate phylogenetic analyses, homologous P. syringae
sequences were collected from the NCBI GenBank database
and the partially completed sequence of P. syringae pv. phaseolicola 1448A genome using tblastx to compare known TTSS
effector protein sequences against the nr nucleotide database
and a custom type III effector gene database. This search
method eliminates any biases or errors due to incomplete or
improper sequence annotation. Homologous protein sequences
were aligned using MultiClustal (Yuan et al. 1999), which runs
iterative ClustalW alignments in order to identify the optimal
alignment parameters. In many cases, final multiple sequence
alignments were adjusted manually. No assumptions concerning orthology or paralogy were imposed on the data due to the
extensive horizontal transfer evident among the hop genes.
Technically, most Hops probably should be considered
xenologs, due to the apparent role of horizontal transfer in
many, but not all, gene families (Rohmer et al. 2004).
Phylogenetic analyses were performed using neighbor-joining (NJ), maximum-likelihood (ML), and Bayesian techniques.
NJ was performed in MEGA2 (ver. 2.1) (Kumar et al. 2001)
using the gamma model with the gamma parameter set at 2.25,
and PHYLIP 3.6a (Felsenstein 1993) using the Jones-TaylorThornton substitution model. Phylogenetic confidence was determined by bootstrapping, using 1,000 replicates. ML analyses were performed in PHYLIP, using the ProML module with
the Jones-Taylor-Thornton model of amino acid change. Bootstrapping was performed using SeqBoot. Bayesian analyses
Vol. 18, No. 4, 2005 / 277

Fig. 1. Maximum likelihood phylogenetic trees for all Hrp outer protein (Hop) families with three or more members. Proposed subgroup names are
demarcated by the vertical bar to the right of the phylogeny. The original name of the effector is in parentheses following the strain designation. The phylogenetic analysis was performed as described in the text. Numbers above the nodes are bootstrap scores. Only bootstrap scores >60 are presented. The
horizontal line below each phylogeny indicated a genetic distance of 0.2.
278 / Molecular Plant-Microbe Interactions

were performed with MrBayes (ver. 3.04b) (Huelsenbeck and
Ronquist 2001) using the Jones-Taylor-Thornton model as a
prior assumption. Each inference consisted of four Markov
chains starting from random trees and running for 500,000
generations. Following the discard of the initial 500 burn-in

trees, 1 tree was sampled every 100 generations, and a 50%
majority-rule consensus tree was generated. Posterior probabilities were calculated to determine the phylogenetic confidence for each node. Phylogenetic trees were viewed in TreeView (Page 1996).

Fig. 1. Continued.
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Effector homology families were defined based on sets of
effectors that could be aligned across their entire length
(global alignment). Homology families were divided into subgroups based on their phylogenetic clustering. The level of
amino acid diversity within and between subgroups was used
as the basis for determining whether a clade deserved a unique
subgroup number within a homology family. Amino acid diversity was calculated with MEGA2 using the gamma model with
the gamma parameter set at 2.25, and standard error calculation via bootstrapping.
Family and subgroup assignments
of previously characterized Hops.
In nearly every case, the three methods (NJ, ML, and Bayesian) produced identical tree topologies. The only exceptions
were AvrD1, HopX (AvrPphE and HopPmaB), HopA (Hop
PsyA and HopPsyB1), and HrpW1, but none of these inconsistencies resulted in a significant change to the subfamily groupings. ML trees for all Hop families with three or more members
are shown in Figure 1, with the exception of HopAM, for
which all three members are identical.
The phylogenetic analyses were used to determine whether
homology families should be subdivided into Hop subgroups
based on amino acid sequence divergence. A homology family
was subdivided if it was found to have within-group amino
acid diversity <0.75 and between-group amino acid diversity
>0.75. The only exception to this rule was in the HopAB family. These cutoff levels were chosen based on the quality of the
alignments and robustness of the phylogenetic reconstruction
at different levels of diversity. For those families that were divided up into subgroups, the average within-subgroup diversity
was 0.23, whereas the average between-subgroup diversity was
1.26. For comparison, the average within-subgroup diversity
for those families that were not subdivided was 0.13, whereas
the between-subgroup diversity for these families was only
0.32. Examples of homology families that were split into subgroups include the HopZ family, which was subdivided into
the HopZ1 subgroup (effectors formerly called HopPmaD and
HopPsyH); the HopZ2 subgroup (AvrPpiG); and the HopZ3
subgroup (HopPsyV or EEL ORF5). Another example is the
HopX family, consisting of HopX1 (AvrPphE) and HopX2
(HopPmaB) (Fig. 1). The HopAB family, which consists of
Hops formerly known as VirPphA, AvrPtoB, HopPmaL, and
HolPmaN, also was split into subgroups. This family proved
particularly challenging because both the Pph 1448A
HopPmaL allele and the Pma ES4326 HolPmaL allele appear
to be truncated homologs of the Pma ES4326 HopPmaL allele,
with the former similar to the C-terminal half and the latter is
similar to the N-terminal half of Pma ES4326 HopPmaL. Consequently, the Pph 1448A HopPmaL and Pma ES4326
HolPmaL alleles do not overlap and, therefore, cannot be analyzed in the same phylogenetic analysis.
Many TTSS effectors share N- or C-terminal homology but
are unrelated over other parts of the protein. These sequences
were termed chimeric effectors and placed in separate homology families. In general, chimerics had regions with very high
alignment quality but could not be aligned across their entire
length. A rather arbitrary decision has been made to consider
Hops that are unalignable over a contiguous stretch of at least
40% of their coding sequence as chimeras. Examples of chimeric effectors include HopK, the N-terminus of which shares
similarity with AvrRps4, and HopD1, which shares similarity
in the N-terminal region with HopAR1 (formerly HopPtoD2).
General conclusions are difficult to draw from the phylogenetic analyses due to the great diversity of effector families.
There are families such as HopX (formerly AvrPphE and
HopPmaB) where effectors appear to be evolving largely in
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concordance with the P. syringae core genome (Deng et al.
2003; Rohmer et al. 2004; Sarkar and Guttman 2004). There
also are families such as HopAB in which large-scale mutational events, such as deletions of large regions of the coding
sequence, appear to occur with some regularity. There are incredibly diverse families such as AvrB, which has been subdivided into three very distinct and strongly supported subgroups, and other families such as HopD (formerly HopPtoD
and AvrPphD), which is extremely well conserved. If there is
one fairly good generality to be made from these analyses, it is
that effector evolution is a highly complex process that frequently is driven by the horizontal movement of selfish elements. These processes have left a pattern of fragmented coding sequences and chimeric molecules in their wake. They also
present a tantalizing picture of the mechanisms by which new
effectors evolve, and by which existing effectors can capture
and co-opt other loci.
Suggested name reassignment
of previously characterized Hops and Avrs.
Hops. Using the results of the phylogenetic analyses, Hops
were assembled into families and subgroups and assigned
names consistent with the new nomenclature guidelines. New
names and subgroup designations for Hop families with three
or more members are indicated in Figure 1. A comprehensive
list of suggested new names for all previously published effectors, together with all known previous aliases, accession numbers, sequences, and evidence categories reflecting the criteria
for Hop naming can be viewed on the Pseudomonas–Plant
Interaction website. To aid in more rapid identification of new
names, a table listing Hops alphabetically by their former
names also is included. Tables posted on the website will be
updated as more Hops are identified.
In the nomenclature system described here, most previously
described Hops retain their original letter designations, with
the pathovar abbreviations moved to the subscript. For example,
the protein formerly published as HopPtoL is now HopL1Pto
DC3000 and HopPmaIPto is HopI1Pto DC3000. Unrelated Hops published under the same letter designation (e.g., HopPsyA,
HopPtoA1, and HopPmaA) have been reviewed by their original discoverers and priority for the alphabetic character determined according to the date of original publication and number of publications related to the protein in question. As in the
case of the HopAB family, we suggest that Hops found to be
members of the same phylogenetic family have their names
changed to reflect this relatedness.
Avrs. Integration of effectors bearing Avr names has presented a greater challenge. In addition to the obvious inconsistency with the Hop nomenclature system, Avr names imply a
specific avirulence phenotype, which often is not shared by
subsequently identified homologs. However, many of the Avr
names are deeply imbedded in the literature and changing
them would lead to a confusing break in well-established lines
of investigation. In the absence of a clear consensus, it has
been left to the original lab of discovery to decide whether a
given Avr family should be incorporated into the proposed
Hop nomenclature.
For AvrA, AvrB, AvrC, AvrD, AvrE, AvrPto, AvrRpm1,
AvrRpt2, and AvrRps4, individual family members will be referred to by their original names. The family will be named
after the founding Avr and subsequently identified homologs
are to be named according to the family name. For example,
AvrRpm1Pma M2 will continue to be called AvrRpm1Pma M2. It is
considered part of the AvrRpm1 family and subsequent homologs will be named AvrRpm1pv strain. Because AvrC is a
member of the AvrB family, future homologs of AvrB and C
will be named for AvrB.

The remaining Avrs, including previously published homologs of AvrPphB, AvrPphE, AvrPphF, VirPphA, AvrPpiB,
AvrPpiC, AvrPpiG, and AvrPtoB, also will be referred to by
their original names. However, the proposed family name will
include both the name of the founding Avr and a new Hop designation. Subsequently identified homologs would be named
according to the Hop name with reference to the founding Avr
early in the text. For example, AvrPphEPto DC3000 has been
assigned to the AvrPphE (HopX) family with subsequent homologs named HopXpv strain.
A final group of TTSS substrates that will retain their earlier
names because of an established literature and close genetic
(and most likely functional) association with the Hrp system
are HrpA (the Hrp pilus protein), HrpK (an apparent translocator), HrpZ (a harpin), and HrpW (another harpin). However,
recently discovered harpin-like proteins encoded outside of the
Hrp pathogenicity island have been given Hop designations.
Phylogenetic classification of new Hops.
To determine whether a protein sequence meets criterion A
for Hop name assignment, or to select a name for Hops confirmed by criteria B, C, or D, the following steps are recommended.
Step 1: conduct BLASTP analyses to determine whether a
given protein is similar to any previously characterized Hops.
If it is not significantly similar to any other Hop, go to step 3.
If it is significantly similar, go to step 2. In this case, significant similarity is roughly defined as a BLAST expect value of
<10–5 and with alignment extending >60% of the length of the
protein.
Step 2: at this stage, a protein can be named and published
using the alphabetic characters of the family to which it is similar (guidelines have been suggested in “Name structure and selection”). However, additional phylogenetic analyses are
strongly recommended in order to generate a more accurate
alignment and assign the protein to a subgroup that reflects its
relationship to other family members. Suggested procedures
for the phylogenetic analyses are listed below, with detailed,
step-by-step instructions provided online.
i) Obtain a file listing the protein sequences of all members
of the Hop family in question from the Pseudomonas–Plant Interaction website. Add the new Hop sequence to the file, and
perform a multiple sequence alignment using Clustal or Multalign. Clustal alignments are easily generated using the
ClustalW tool available through the EMBL website. New Hops
for which a contiguous stretch of ≥40% of the coding region is
unique or derived from an unrelated Hop should be considered
chimeras and assigned a novel alphabetic character (see step
3). Proteins that appear to be truncated or disrupted members
of an established Hop family do not require novel alphabetic
characters.
ii) Download the free MEGA2 package available online. Using utilities available through the pull down menu in MEGA2,
convert the Clustal .aln file to MEGA format and perform
neighbor-joining, minimum evolution, or maximum parsimony
analysis with bootstrapping to determine how the new Hop
clusters within the existing family and subgroups. Alternative
phylogenetic methods such as maximum likelihood or Bayesian
analysis also can be performed, although the software supporting these methods is not as transparent as MEGA2.
iii) If a new Hop phylogenetically clusters with an existing
family and subgroup, it should be named using the same alphabetic character and subgroup number as its homologs.
iv) Alternatively, if the new Hop diverges from existing subgroups within a family, use MEGA2 to calculate the genetic
distance of the new Hop from the established subgroups. As a
general rule, when genetic distance is calculated using the

gamma model, with the gamma parameter set at 2.25, the distance between Hops within a subgroup will be less than 0.75.
Those in separate subgroups will have a distance greater than
0.75.
v) If it is determined that the Hop warrants creation of a new
subgroup, it should be named with the alphabetic character of
the homologous Hop family followed by the next available numeric designation. Proceed to step 4.
Step 3: in the absence of homology to a pre-existing Hop
family, confirm Hop identity using criteria B, C, or D. Go to
the list of Hop names online and select the next available alphabetic character and subgroup number of “1”.
Step 4: submit the sequence and name of the new Hop to
GenBank for immediate release.
Priority for name assignment.
Priority for naming will be determined according to the date
on which the sequences and names of new Hops are made
public in the GenBank database. Release via GenBank ensures
that anyone subsequently identifying the same Hop will learn
of the prior name assignment during routine BLAST searches.
Researchers who do not wish their sequences to be public for
an extended time before publication are free to delay both official name assignment and sequence release until the time of
manuscript submission.
Database management.
The new nomenclature has been designed to ensure that
newly discovered effectors are systematically assigned unique
names. To minimize confusion over the names for previously
characterized effectors, a database of all known effectors
including former names and aliases is available on the Pseudomonas–Plant Interaction website. Names also have been updated in the Pseudomonas syringae pv. tomato DC3000 genome annotation at GenBank. Given that GenBank remains the
ultimate repository of information, and that only the original
depositors can change records, it is requested that other research
groups similarly update their previous GenBank depositions.
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